arrow
L

Lucía Boix-Palop

Department of Medicine
H指数:20
被引数:1,538

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nasopharyngeal microbiota profiles and lytA-PCR status in adult pneumococcal pneumonia: distinct microbial communities and diagnostic implications

鼻咽微生物组特征和lytA-PCR状态在成人肺炎链球菌肺炎中的研究:不同的微生物群落和诊断意义

2026-08-050
OA
Mortality risk of ESBL producers in Escherichia coli bacteraemia: a comprehensive analysis using the PROBAC cohort

产超广谱β-内酰胺酶(ESBL)的大肠杆菌(Escherichia coli)败血症的死亡风险:一项使用PROBAC队列的全面分析

2026-04-080
OA
A matched case-control study on Escherichia coli factors contributing to sepsis and septic shock in bacteraemic patients

一项关于导致菌血症患者脓毒症和脓毒性休克的大肠杆菌因素的匹配病例对照研究

2026-01-120
OAAI
Analysis of Clinical Subphenotypes in Methicillin-Resistant Staphylococcus aureus Bacteremia: A Post Hoc Analysis of the MRSA-GEIRAS-SEIMC Study

甲氧西林耐药金黄色葡萄球菌菌血症的临床亚型分析:MRSA-GEIRAS-SEIMC研究的回顾性分析

2025-12-010
PRE
Development and validation of a predictive mortality scoring model for bloodstream infections due to Escherichia coli in the PROBAC cohort

基于PROBAC队列的由大肠杆菌引起的血流感染死亡风险预测评分模型的开发与验证

2025-07-230
OA
External validation of the predictive ability of Charson, SOFA, Pitt, INCREMENT-ESBL and bloodstream infection mortality Risk for 30-day-mortality in bacteraemia using the PROBAC cohort data

使用PROBAC队列数据对外源性Charson、SOFA、Pitt、INCREMENT-ESBL和血流感染死亡率风险模型的30天死亡率预测能力进行外部验证。

2025-07-090
PRE
Effectiveness of oral step-down therapy and early oral switch for bloodstream infections caused by Enterobacterales: A post hoc emulation trial of the SIMPLIFY trial

肠杆菌科细菌血流感染中口服降级疗法和早期口服转换的疗效:SIMPLIFY试验的后续模拟试验

2025-07-010
OAAI
Real-world evidence of dalbavancin effectiveness as consolidation therapy in infective endocarditis due to Enterococcus spp.

达巴万星作为肠球菌属所致感染性心内膜炎巩固治疗的有效性真实世界证据。

2025-03-170
OAAI
Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients
2025-02-210
OAAI
Infective endocarditis caused by penicillin-resistant viridans group streptococci: a series of nine cases from a Spanish cohort

耐青霉素草绿色链球菌引起的感染性心内膜炎: 来自西班牙队列的9例病例

2024-10-010
PRE
Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain
2024-09-011
OAAI
Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study

粪肠球菌与屎肠球菌血流感染的临床特征、易感因素和结局: 一项前瞻性多中心队列研究

2024-08-080
OAAI
Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study

微生物因素与脓毒症/脓毒性休克大肠杆菌菌血症死亡率的关系: 一项前瞻性队列研究

2024-08-010
OA
A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study
2024-06-120
PRE
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

抗假单胞菌 β-内酰胺类药物结构化降阶梯治疗肠杆菌血流感染的有效性和安全性 (SIMPLIFY): 一项开放标签、多中心、随机试验

2024-04-016
PRE
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
2023-10-026
OAAI